✦ LIBER ✦

Hepatotoxicity of Tyrosine Kinase Inhibitors: Clinical and Regulatory Perspectives

✍ Scribed by Shah, Rashmi R.; Morganroth, Joel; Shah, Devron R.

Book ID: 120284137
Publisher: Springer International Publishing AG
Year: 2013
Tongue: English
Weight: 322 KB
Volume: 36
Category: Article
ISSN: 0114-5916
DOI: 10.1007/s40264-013-0048-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tyrosine kinase inhibitors: A clinical p

Tyrosine kinase inhibitors: A clinical perspective

✍ Sanjay Goel; Sridhar Mani; Roman Perez-Soler 📂 Article 📅 2002 🏛 Current Science Inc. 🌐 English ⚖ 579 KB

Clinical pharmacology of tyrosine kinase

Clinical pharmacology of tyrosine kinase inhibitors becoming generic drugs: the regulatory perspective

✍ Eckstein, Niels; Röper, Lea; Haas, Bodo; Potthast, Henrike; Hermes, Ulrike; Unkr 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 369 KB

Clinical perspectives for irreversible t

Clinical perspectives for irreversible tyrosine kinase inhibitors in cancer

✍ Caterina Carmi; Marco Mor; Pier Giorgio Petronini; Roberta R. Alfieri 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 774 KB

Clinical pharmacokinetics of tyrosine ki

Clinical pharmacokinetics of tyrosine kinase inhibitors

✍ Nielka P. van Erp; Hans Gelderblom; Henk-Jan Guchelaar 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 380 KB

Clinical Pharmacokinetics of Tyrosine Ki

Clinical Pharmacokinetics of Tyrosine Kinase Inhibitors

✍ Matthias Scheffler, Paola Di Gion, Oxana Doroshyenko, Jürgen Wolf, Prof. Dr med. 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 329 KB

Clinical Pharmacokinetics of Tyrosine Ki

Clinical Pharmacokinetics of Tyrosine Kinase Inhibitors

✍ Paola Di Gion, Friederike Kanefendt, Andreas Lindauer, Matthias Scheffler, Oxana 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 484 KB